CY1112686T1 - Χρηση l-καρνιτινης για τη θεραπεια καρδιαγγειακων νοσηματων - Google Patents
Χρηση l-καρνιτινης για τη θεραπεια καρδιαγγειακων νοσηματωνInfo
- Publication number
- CY1112686T1 CY1112686T1 CY20121100341T CY121100341T CY1112686T1 CY 1112686 T1 CY1112686 T1 CY 1112686T1 CY 20121100341 T CY20121100341 T CY 20121100341T CY 121100341 T CY121100341 T CY 121100341T CY 1112686 T1 CY1112686 T1 CY 1112686T1
- Authority
- CY
- Cyprus
- Prior art keywords
- carnitine
- treatment
- infarction
- grams
- days
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η χρήση L-καρνιτίνης ή ενός από τα φαρμακευτικά αποδεκτά άλατά της, περιγράφεται σε συνδυασμό με γλυκόζη για την παρασκευή ενός φαρμάκου χρήσιμου για την ελάττωση του αριθμού θανάτων που προκαλούνται από οξύ έμφραγμα του μυοκαρδίου, για τη μείωση του αριθμού των ημερών που περνούν οι ασθενείς που έχουν υποστεί έμφραγμα στη μονάδα εντατικής θεραπείας στο νοσοκομείο και για τη μείωση του αριθμού των επεισοδίων μετεμφραγματικής καρδιακής ανεπάρκειας, όπου η L-καρνιτίνη χορηγείται ενδοφλέβια εντός μόνο ελαχίστων ωρών από την εκδήλωση των συμπτωμάτων του οξέος εμφράγματος του μυοκαρδίου σε μια αρχική δόση 9 γραμμαρίων την ημέρα σε συνδυασμό με 1000-1500 mL ενός διαλύματος 5% γλυκόζης για 5 ημέρες, μετά από τις οποίες η θεραπεία με L-καρνιτίνη συνεχίζεται σε μια δόση 4 γραμμαρίων την ημέρα η οποία χορηγείται από τη στοματική οδό.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000346A ITRM20040346A1 (it) | 2004-07-13 | 2004-07-13 | Uso della l-carnitina per il trattamento di patologie cardiovascolari. |
EP05755616A EP1773314B1 (en) | 2004-07-13 | 2005-06-21 | Use of l-carnitine for the treatment of cardiovascular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112686T1 true CY1112686T1 (el) | 2016-02-10 |
Family
ID=34971575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100341T CY1112686T1 (el) | 2004-07-13 | 2012-04-05 | Χρηση l-καρνιτινης για τη θεραπεια καρδιαγγειακων νοσηματων |
Country Status (22)
Country | Link |
---|---|
US (2) | US7879908B2 (el) |
EP (1) | EP1773314B1 (el) |
JP (1) | JP5230195B2 (el) |
KR (1) | KR101296479B1 (el) |
CN (2) | CN101087602B (el) |
AT (1) | ATE542529T1 (el) |
AU (1) | AU2005262050B2 (el) |
BR (1) | BRPI0513303A8 (el) |
CA (1) | CA2569888C (el) |
CY (1) | CY1112686T1 (el) |
DK (1) | DK1773314T3 (el) |
ES (1) | ES2380913T3 (el) |
HK (2) | HK1113542A1 (el) |
HR (1) | HRP20120178T1 (el) |
IT (1) | ITRM20040346A1 (el) |
ME (1) | ME01345B (el) |
MX (1) | MXPA06014665A (el) |
PL (1) | PL1773314T3 (el) |
PT (1) | PT1773314E (el) |
RS (1) | RS52253B (el) |
SI (1) | SI1773314T1 (el) |
WO (1) | WO2006005415A2 (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR086543A1 (es) * | 2011-05-25 | 2014-01-08 | Bg Medicine Inc | Inhibidores de galectina-3 y metodos de uso de los mismos, composicion farmaceutica |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1120033B (it) * | 1979-10-05 | 1986-03-19 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale |
JPS6415220A (en) | 1987-07-06 | 1989-01-19 | Mitsubishi Electric Corp | Tension control device for utilizing maximum torque and maximum electric current of winding motor |
JPH06102624B2 (ja) * | 1990-08-10 | 1994-12-14 | アース製薬株式会社 | 非心臓由来の不整脈防止薬 |
IT1261695B (it) * | 1993-06-02 | 1996-05-29 | Sigma Tau Ind Farmaceuti | Impiego di l-carnitina e alcanoil l-carnitine nella conservazione del sangue per trasfusioni e soluzioni stabilizzatrici che le contengono. |
US5998386A (en) * | 1997-09-19 | 1999-12-07 | Feldman; Arthur M. | Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue |
CA2352485A1 (en) * | 1998-11-26 | 2000-06-02 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of fumarate salt of l-carnitine or its alkanoyl derivatives in ischaemia |
ES2270620T3 (es) * | 1999-10-11 | 2007-04-01 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Uso de l-carnitina y sus derivados alcanoilo como agentes osmoticos en soluciones para uso medico. |
JP4674046B2 (ja) * | 2002-04-01 | 2011-04-20 | ザ ガバナーズ オブ ザ ユニバーシティ オブ アルバータ | グルコース利用を刺激する化合物および使用方法 |
ITRM20030178A1 (it) * | 2003-04-17 | 2004-10-18 | Sigma Tau Ind Farmaceuti | Uso della l-carnitina per il trattamento di patologie cardiovascolari. |
-
2004
- 2004-07-13 IT IT000346A patent/ITRM20040346A1/it unknown
-
2005
- 2005-06-21 AU AU2005262050A patent/AU2005262050B2/en not_active Ceased
- 2005-06-21 PL PL05755616T patent/PL1773314T3/pl unknown
- 2005-06-21 MX MXPA06014665A patent/MXPA06014665A/es not_active Application Discontinuation
- 2005-06-21 AT AT05755616T patent/ATE542529T1/de active
- 2005-06-21 ME MEP-2012-32A patent/ME01345B/me unknown
- 2005-06-21 PT PT05755616T patent/PT1773314E/pt unknown
- 2005-06-21 JP JP2007520688A patent/JP5230195B2/ja not_active Expired - Fee Related
- 2005-06-21 RS RS20120095A patent/RS52253B/en unknown
- 2005-06-21 WO PCT/EP2005/006657 patent/WO2006005415A2/en active Application Filing
- 2005-06-21 CN CN2005800234751A patent/CN101087602B/zh active Active
- 2005-06-21 US US11/629,202 patent/US7879908B2/en active Active
- 2005-06-21 ES ES05755616T patent/ES2380913T3/es active Active
- 2005-06-21 DK DK05755616.9T patent/DK1773314T3/da active
- 2005-06-21 EP EP05755616A patent/EP1773314B1/en active Active
- 2005-06-21 KR KR1020077000711A patent/KR101296479B1/ko active IP Right Grant
- 2005-06-21 CN CN201110226409.1A patent/CN102349923B/zh active Active
- 2005-06-21 SI SI200531481T patent/SI1773314T1/sl unknown
- 2005-06-21 BR BRPI0513303A patent/BRPI0513303A8/pt not_active Application Discontinuation
- 2005-06-21 CA CA2569888A patent/CA2569888C/en active Active
-
2008
- 2008-03-13 HK HK08102916.9A patent/HK1113542A1/xx not_active IP Right Cessation
-
2010
- 2010-12-20 US US12/972,617 patent/US8394854B2/en active Active
-
2012
- 2012-02-22 HR HRP20120178TT patent/HRP20120178T1/hr unknown
- 2012-04-05 CY CY20121100341T patent/CY1112686T1/el unknown
- 2012-07-10 HK HK12106717.5A patent/HK1166003A1/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2530719T3 (es) | Formulaciones de oxicodona para ser administradas una vez al día | |
ES2709339T3 (es) | Tratamiento de la diabetes mellitus mediante formulaciones de insulinas de acción prolongada | |
Lindgren et al. | Diclofenac for pain after hip surgery | |
PL404315A1 (pl) | Lek i kompozycja farmaceutyczna zawierajaca 5-hydroksy-7-chloro-1[2-metylo-4(2-metylobenzoiloamino)benzoilo]-2,3,4,5-tetrahydro-1H-benzoazepine do leczenia ciezkiej niewydolnosci serca oraz zastosowanie tego zwiazku do wytwarzania leku | |
CA2593171A1 (en) | Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases | |
JP7208139B2 (ja) | 双極性障害の予防、軽減又は治療のためのカルバメート化合物の使用 | |
CY1112686T1 (el) | Χρηση l-καρνιτινης για τη θεραπεια καρδιαγγειακων νοσηματων | |
KR20120089623A (ko) | 정맥내 투여용 이부프로펜을 이용한 환자의 치료 | |
CA2450915A1 (en) | Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure | |
CA2493208A1 (en) | Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure | |
MXPA05007612A (es) | Uso de l-carnitina para el tratamiento de enfermedades cardiovasculares. | |
Poole-Wilson | Timolol maleate (MK 950) in the treatment of essential hypertension | |
Henrikson et al. | Calcium channel blocker overdose mimicking an acute myocardial infarction | |
Prabhu et al. | Digital gangrene due to dopamine infusion-a case report | |
ROY et al. | Milestones In Diabetes Research | |
JP2008517872A5 (el) | ||
PE20240241A1 (es) | Una composicion farmaceutica que comprende acido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxilo | |
Ayache et al. | Methylphenidate in a patient with depression and respiratory insufficiency | |
McDaniel | Antidepressant activity of linezolid | |
Subramanian et al. | Escherichia coli sepsis as a precipitant of stress cardiomyopathy: A systematic review | |
RU2006124882A (ru) | Способ комплексной инфузионной терапии у больных с гипергликемической кетоацидотической диабетической комой | |
UA70535A (en) | Method for preventing paroxysms of atrial fibrillamethod for preventing paroxysms of atrial fibrillation in ischemic disease of heart in elderly tion in ischemic disease of heart in elderly |